Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson’s Disease without Dementia

Abstract Objective Cognitive changes are heterogeneous in Parkinson’s disease (PD). This study compared whether anticholinergic burden drives differences in cognitive domain performance and empirically-derived PD-cognitive phenotypes. Method A retrospective chart review contained participants (n = 4...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of clinical neuropsychology 2024-11, Vol.39 (8), p.1443-1449
Hauptverfasser:	Santos, Lauren G, Kenney, Lauren E, Ray, Alyssa, Paredes, Alfredo, Ratajska, Adrianna M, Eversole, Kara, Patel, Bhavana, Rawls, Ashley E, Okun, Michael S, Bowers, Dawn
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Cholinergic Antagonists - adverse effects Cognition - drug effects Cognitive Dysfunction - chemically induced Cognitive Dysfunction - etiology Dementia Executive Function - drug effects Executive Function - physiology Female Humans Male Middle Aged Neuropsychological Tests - statistics & numerical data Parkinson Disease - complications Parkinson Disease - drug therapy Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!